Metabolic syndrome and its relationship with negative symptoms in female patients with schizophrenia
Romanian Journal of Psychiatry and Psychotherapy · 2016
DOI: 10.37897/rjpp.2016.3.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Psychiatry and Psychotherapy, 2016. Verfasst von Codruta A. Botis und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
High prevalence of metabolic syndrome has been reported in patients with schizophrenia. Factors that contribute to the development of physical and biochemical abnormalities due to this syndrome are: sedentary lifestyle, antipsychotic medication, mental disorder related issues, including negative symptomatology and genetic factors. A significant association between negative symptoms, obesity and metabolic syndrome has been reported in recent studies.
Objectives
The objectives of this study were to estimate the frequency of metabolic syndrome and to examine the association between metabolic syndrome and negative symptoms in female patients with schizophrenia.
Methods
Forty for female patients diagnosed with schizophrenia were recruited from psychiatric out-patient clinic. Patients underwent one assessment for metabolic syndrome parameters which included anthropometrical measurements, blood pressure, lipid profile, fasting plasma glucose level. The presence of the metabolic syndrome was determined using the International Diabetes Federation criteria. The Positive and Negative Syndrome Scale was used for characterizing symptoms.
Results
Mean duration of illness was 13.93 years and mean duration of education was 13.15 years. Metabolic syndrome was found in 52.27% of the patients (36% with hypertriglyceridemia, 86% with high waist circumference, 59% with low HDL cholesterol, 20.45% with high fasting glucose and 11% with hypertension. The frequency of metabolic syndrome in group patients with predominant negative symptoms was significantly higher (p= 0.0026) compared to the group without predominant negative symptoms.
Conclusions
Metabolic syndrome is common in female patients with schizophrenia. Systematically assessment of the various components of metabolic syndrome and adequate treatment should help to reduce the cardiovascular risk and mortality in patients with schizophrenia.
Zitieren
APA
Botis, C. A., & Miclutia, I. V. (2016). Metabolic syndrome and its relationship with negative symptoms in female patients with schizophrenia. Romanian Journal of Psychiatry and Psychotherapy. https://doi.org/10.37897/rjpp.2016.3.4
Vancouver
Botis CA, Miclutia IV. Metabolic syndrome and its relationship with negative symptoms in female patients with schizophrenia. Romanian Journal of Psychiatry and Psychotherapy. 2016. doi:10.37897/rjpp.2016.3.4
BibTeX
@article{Botis2016,
author = {Botis, Codruta A. and Miclutia, Ioana V.},
title = {Metabolic syndrome and its relationship with negative symptoms in female patients with schizophrenia},
journal = {Romanian Journal of Psychiatry and Psychotherapy},
year = {2016},
doi = {10.37897/rjpp.2016.3.4}
}
EUVIMED